Published in World J Hepatol on April 27, 2012
Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps. Front Pharmacol (2015) 1.04
Hepatotoxicity by Dietary Supplements: A Tabular Listing and Clinical Characteristics. Int J Mol Sci (2016) 0.82
SlimQuick™-Associated Hepatotoxicity Resulting in Fulminant Liver Failure and Orthotopic Liver Transplantation. ACG Case Rep J (2014) 0.79
Herbal and Dietary Supplement-Induced Liver Injury. Clin Liver Dis (2016) 0.75
Risk of Liver Injury Associated with Green Tea Extract in SLIMQUICK(®) Weight Loss Products: Results from the DILIN Prospective Study. Drug Saf (2016) 0.75
Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology (2008) 5.45
Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev (2009) 2.14
Darkroom hepatitis after exposure to hydroquinone. Lancet (1995) 2.13
The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention. Arch Biochem Biophys (2010) 1.98
Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol (2009) 1.96
Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice. Food Chem Toxicol (2009) 1.76
Safety of green tea extracts : a systematic review by the US Pharmacopeia. Drug Saf (2008) 1.73
Green tea: potential health benefits. Am Fam Physician (2009) 1.66
Heterozygous MZ alpha 1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis. N Engl J Med (1981) 1.40
Increased risk of chronic liver failure in adults with heterozygous alpha1-antitrypsin deficiency. Hepatology (1998) 1.19
Hepatotoxicity due to hydroxycut: a case series. Am J Gastroenterol (2010) 1.14
Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study. J Pediatr Gastroenterol Nutr (2006) 1.01
Serious adverse liver reactions associated with herbal weight-loss supplements. J Hepatol (2007) 0.98
A case of veno-occlusive disease of the liver in Britain associated with herbal tea consumption. J Clin Pathol (1976) 0.94
Late manifestation of chronic liver disease in adults with alpha-1-antitrypsin deficiency. Dig Dis Sci (1987) 0.93
Urinary excretion and metabolism of arbutin after oral administration of Arctostaphylos uvae ursi extract as film-coated tablets and aqueous solution in healthy humans. J Clin Pharmacol (2002) 0.91
Alpha-1-antitrypsin phenotypes in adult liver disease patients. Ups J Med Sci (2009) 0.83
Green tea and cancer. Lancet Oncol (2010) 0.79
Severe chemotherapy-related hepatic toxicity associated with MZ protease inhibitor phenotype. Am J Pediatr Hematol Oncol (1990) 0.79
Hydroquinone and hepatitis. Lancet (1995) 0.78
Quality assessment of colonoscopic cecal intubation: an analysis of 6 years of continuous practice at a university hospital. Am J Gastroenterol (2006) 3.49
Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. Cancer Discov (2012) 2.39
Ureteral stents are associated with reduced risk of ureteral complications after kidney transplantation: a large single center experience. Transplantation (2012) 1.79
Global hypomethylation of genomic DNA in cancer-associated myofibroblasts. Cancer Res (2008) 1.70
Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease. Liver Transpl (2009) 1.67
Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: a case-control study. Transplantation (2009) 1.66
Shorter waitlist times and improved graft survivals are observed in patients who accept hepatitis C virus+ renal allografts. Transplantation (2015) 1.48
Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors. Biochem Pharmacol (2005) 1.44
Muscarinic receptors and ligands in cancer. Am J Physiol Cell Physiol (2008) 1.42
Interacinar c4d staining in pancreas allografts. Transplantation (2009) 1.41
Human cecal bile acids: concentration and spectrum. Am J Physiol Gastrointest Liver Physiol (2007) 1.35
Matrix metalloproteinase-7-catalyzed release of HB-EGF mediates deoxycholyltaurine-induced proliferation of a human colon cancer cell line. Biochem Pharmacol (2006) 1.30
Transactivation of the epidermal growth factor receptor mediates cholinergic agonist-induced proliferation of H508 human colon cancer cells. Cancer Res (2003) 1.28
Computational models for drug inhibition of the human apical sodium-dependent bile acid transporter. Mol Pharm (2009) 1.26
Liquid nitrogen spray cryotherapy in Barrett's esophagus with high-grade dysplasia: long-term results. Gastrointest Endosc (2013) 1.20
Acetylcholine-induced activation of M3 muscarinic receptors stimulates robust matrix metalloproteinase gene expression in human colon cancer cells. Am J Physiol Gastrointest Liver Physiol (2009) 1.19
Acetylcholine release by human colon cancer cells mediates autocrine stimulation of cell proliferation. Am J Physiol Gastrointest Liver Physiol (2008) 1.19
Management of early hepatocellular carcinoma in patients with well-compensated cirrhosis. Ann Surg Oncol (2009) 1.07
3',5'-Cyclic diguanylic acid (c-di-GMP) inhibits basal and growth factor-stimulated human colon cancer cell proliferation. Biochem Biophys Res Commun (2005) 1.07
Functional interaction of lithocholic acid conjugates with M3 muscarinic receptors on a human colon cancer cell line. Biochim Biophys Acta (2002) 1.07
A decade of experience with renal transplantation in African-Americans. Ann Surg (2002) 1.06
Surgical management of early-stage hepatocellular carcinoma: resection or transplantation? J Gastrointest Surg (2008) 1.04
Muscarinic receptor agonists stimulate human colon cancer cell migration and invasion. Am J Physiol Gastrointest Liver Physiol (2011) 1.01
Akt-dependent NF-kappaB activation is required for bile acids to rescue colon cancer cells from stress-induced apoptosis. Exp Cell Res (2008) 1.00
Single-port donor nephrectomy provides improved patient satisfaction and equivalent outcomes. Ann Surg (2013) 0.99
Acute graft-versus-host disease in pancreas transplantation: a comparison of two case presentations and a review of the literature. Transplantation (2006) 0.98
MIC expression in renal and pancreatic allografts. Transplantation (2002) 0.97
Vasodilatory effects of cholinergic agonists are greatly diminished in aorta from M3R-/- mice. Eur J Pharmacol (2004) 0.96
Bile acids regulate cardiovascular function. Clin Transl Sci (2011) 0.95
Sarcopenia adversely impacts postoperative complications following resection or transplantation in patients with primary liver tumors. J Gastrointest Surg (2014) 0.94
Src-mediated aryl hydrocarbon and epidermal growth factor receptor cross talk stimulates colon cancer cell proliferation. Am J Physiol Gastrointest Liver Physiol (2012) 0.94
Total face, double jaw, and tongue transplant research procurement: an educational model. Plast Reconstr Surg (2012) 0.93
Are all melanomas the same? Spitzoid melanoma is a distinct subtype of melanoma. Cancer (2006) 0.92
NEU1 sialidase expressed in human airway epithelia regulates epidermal growth factor receptor (EGFR) and MUC1 protein signaling. J Biol Chem (2012) 0.92
Cholinergic agonist-induced pepsinogen secretion from murine gastric chief cells is mediated by M1 and M3 muscarinic receptors. Am J Physiol Gastrointest Liver Physiol (2005) 0.91
The RNA-binding protein CUG-BP1 increases survivin expression in oesophageal cancer cells through enhanced mRNA stability. Biochem J (2012) 0.90
Three-year Results of a Pilot Program in Early Liver Transplantation for Severe Alcoholic Hepatitis. Ann Surg (2017) 0.90
Deoxycholyltaurine-induced vasodilation of rodent aorta is nitric oxide- and muscarinic M(3) receptor-dependent. Eur J Pharmacol (2005) 0.89
In vivo performance of a novel fluorinated magnetic resonance imaging agent for functional analysis of bile acid transport. Mol Pharm (2014) 0.89
Hepatitis C knowledge among primary care residents: is our teaching adequate for the times? Am J Gastroenterol (2004) 0.88
A survey of credentialing practices of gastrointestinal endoscopy centers in the United States. J Clin Gastroenterol (2005) 0.88
Racial/ethnic disparity in kidney transplantation outcomes: influence of donor and recipient characteristics. J Natl Med Assoc (2009) 0.87
Cholinergic muscarinic receptor activation augments murine intestinal epithelial cell proliferation and tumorigenesis. BMC Cancer (2013) 0.87
Heterozygosity for factor V Leiden and G20210A prothrombin genotypes in a patient with mesenteric vein thrombosis. Dig Dis Sci (2002) 0.86
Muscarinic receptor signaling in colon cancer. Cancers (Basel) (2011) 0.86
Lithocholylcholine, a bile acid/acetylcholine hybrid, is a muscarinic receptor antagonist. J Pharmacol Exp Ther (2002) 0.86
Design and characterization of a novel fluorinated magnetic resonance imaging agent for functional analysis of bile Acid transporter activity. Pharm Res (2013) 0.84
Deceased-donor renal transplantation in the geriatric population demonstrates equal graft survival compared with younger recipients. Transplantation (2009) 0.84
Scopolamine treatment and muscarinic receptor subtype-3 gene ablation augment azoxymethane-induced murine liver injury. J Pharmacol Exp Ther (2010) 0.84
Effects of deoxycholylglycine, a conjugated secondary bile acid, on myogenic tone and agonist-induced contraction in rat resistance arteries. PLoS One (2012) 0.84
Thymoglobulin dose optimization for induction therapy in high risk kidney transplant recipients. Transplantation (2008) 0.83
NEU1 and NEU3 sialidase activity expressed in human lung microvascular endothelia: NEU1 restrains endothelial cell migration, whereas NEU3 does not. J Biol Chem (2012) 0.83
A 40-year-old man with a perforated cheek. Am J Med Sci (2011) 0.82
Solitary renal allografts from pediatric cadaver donors less than 2 years of age transplanted into adult recipients. Transplantation (2004) 0.82
RNase-L deficiency exacerbates experimental colitis and colitis-associated cancer. Inflamm Bowel Dis (2013) 0.82
Adenomatoid tumor of the testis with intratesticular growth: a case report and review of the literature. Int J Surg Pathol (2011) 0.81
Pancreas transplant alone as an independent risk factor for the development of renal failure: a retrospective study. Transplantation (2008) 0.81
Design and evaluation of a novel trifluorinated imaging agent for assessment of bile acid transport using fluorine magnetic resonance imaging. J Pharm Sci (2014) 0.81
Comparative performances of staging systems for early hepatocellular carcinoma. HPB (Oxford) (2009) 0.81
Endoscopic resection of an ileal inflammatory fibroid polyp using retrograde single-balloon enteroscopy. Clin Gastroenterol Hepatol (2009) 0.81
Intraoperative coil embolization reduces transplant nephrectomy transfusion requirement. Vasc Endovascular Surg (2007) 0.81
Daclizumab induction in solid organ transplantation. Expert Opin Biol Ther (2004) 0.80
Comparison of seven liver allocation models with respect to lives saved among patients on the liver transplant waiting list. Transpl Int (2012) 0.80
Molecular Interactions between MUC1 Epithelial Mucin, β-Catenin, and CagA Proteins. Front Immunol (2012) 0.80
Effects of modulating M3 muscarinic receptor activity on azoxymethane-induced liver injury in mice. Biochem Pharmacol (2013) 0.79
Src-mediated cross-talk between farnesoid X and epidermal growth factor receptors inhibits human intestinal cell proliferation and tumorigenesis. PLoS One (2012) 0.79
Use of activated recombinant human factor VII (rhFVIIa) for colonic polypectomies in patients with cirrhosis and coagulopathy. Dig Dis Sci (2003) 0.79
Gastrointestinal peptides and regulation of gastric acid secretion. Curr Opin Endocrinol Diabetes Obes (2010) 0.79
The impact of reduced immunosuppression on graft outcomes in elderly renal transplant recipients. Clin Transplant (2009) 0.78
Slc10a2-null mice uncover colon cancer-promoting actions of endogenous fecal bile acids. Carcinogenesis (2015) 0.78
The Cdc42/Rac nucleotide exchange factor protein β1Pix (Pak-interacting exchange factor) modulates β-catenin transcriptional activity in colon cancer cells: evidence for direct interaction of β1PIX with β-catenin. J Biol Chem (2013) 0.78
Rescue therapy for early antibody mediated rejection with a proteasome inhibitor: a case report. Clin Transpl (2009) 0.78
Should living-unrelated renal transplant recipients receive antibody induction? Results of a clinical experience trial. Transplantation (2004) 0.78
Valganciclovir is an effective prophylaxis for cytomegalovirus disease in liver transplant recipients. HPB (Oxford) (2010) 0.78
Treatment of major hepatic necrosis: lobectomy versus serial debridement. J Trauma (2010) 0.77
Platelet sparing effect of COX II inhibition used with pegylated interferon alfa-2a for the treatment of chronic hepatitis C: a short term pilot study. Cytokine (2004) 0.77
Type 3 Muscarinic Receptors Contribute to Clearance of Citrobacter rodentium. Inflamm Bowel Dis (2015) 0.77
Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis. Med Oncol (2014) 0.76
Human airway epithelia express catalytically active NEU3 sialidase. Am J Physiol Lung Cell Mol Physiol (2014) 0.76
Radiofrequency ablation in patients with hepatocellular carcinoma. Hepatology (2009) 0.75
Bedside to bench: role of muscarinic receptor activation in ultrarapid growth of colorectal cancer in a patient with pheochromocytoma. Mayo Clin Proc (2013) 0.75
Renal dysfunction in cirrhosis. Curr Opin Gastroenterol (2015) 0.75
Anatomic classification of the endoscopic appearance of the normal appendiceal orifice: a novel tool for recognition and documentation of cecal intubation. Clin Anat (2011) 0.75
Declining gastrointestinal opportunistic infections in HIV-infected persons: a triumph of science and a challenge for our HAARTs and minds. Am J Gastroenterol (2005) 0.75
Postoperative infections in cirrhotic patients. Hepatogastroenterology (2005) 0.75
Microvascular Invasion in Hepatocellular Carcinoma and Liver Transplant. Exp Clin Transplant (2016) 0.75
Rescue therapy for acute antibody mediated rejection with a proteosome inhibitor after kidney transplantation. Clin Transpl (2010) 0.75
Safety and efficacy of micafungin in transplantation recipients. Transplantation (2006) 0.75
Predictive Modeling of Massive Transfusion Requirements During Liver Transplantation and Its Potential to Reduce Utilization of Blood Bank Resources. Anesth Analg (2017) 0.75
Seroprevalence of H. pylori infection and symptoms of upper gastrointestinal tract disease in two groups of health-care workers. Dig Dis Sci (2002) 0.75
Ectopic ureter presenting as anterior wall vaginal prolapse. Female Pelvic Med Reconstr Surg (2014) 0.75
Pre- Versus Posttransplant Treatment of Hepatitis C Virus With Direct-Acting Antivirals in Liver Transplant Recipients: More Issues to be Solved. Exp Clin Transplant (2017) 0.75
Venacavoscopy during nephrectomy for renal cell carcinoma with inferior vena caval thrombus. J Urol (2006) 0.75
Early steroid withdrawal in solitary pancreas transplantation results in equivalent graft and patient survival compared with maintenance steroid therapy. Clin Transplant (2007) 0.75
Recombinant human factor VIIa-induced alterations in tissue factor and thrombomodulin in patients with advanced liver cirrhosis. J Gastroenterol Hepatol (2005) 0.75
Antibody-mediated rejection of renal allograft in combined liver-kidney transplant. Clin Transplant (2010) 0.75